Acetic Acid → Diethyl trans-1-benzyl-4-methoxypiperidin-3-ylphosphoramidate

HRID 875629Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 875629
[CH3:1][O:2][C@@H:3]1[CH2:8][CH2:7][NH:6][CH2:5][C@H:4]1[NH:9][P:10](=[O:17])([O:14][CH2:15][CH3:16])[O:11][CH2:12][CH3:13].[CH:18](=O)[C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1.C(O)(=O)C.[BH3-]C#N.[Na+]>CO>[CH2:18]([N:6]1[CH2:7][CH2:8][C@@H:3]([O:2][CH3:1])[C@H:4]([NH:9][P:10](=[O:17])([O:14][CH2:15][CH3:16])[O:11][CH2:12][CH3:13])[CH2:5]1)[C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1

Komponenten

6

Reaktionsbedingungen

Temperatur
0 °C

Versuchsvorschrift

A mixture of diethyl trans-4-methoxypiperidin-3-ylphosphoramidate (1.30 g, 4.88 mmol), benzaldehyde (0.74 mL, 7.32 mmol) and acetic acid (0.56 mL, 9.76 mmol) in methanol (20 mL) was stirred at 0° C. for 30 minutes. NaCNBH3 (0.46 g, 7.32 mmol) was added at 0° C. The resulting solution was warmed to room temperature and stirred at room temperature for 1 hour. The solvent was removed in vacuo and saturated sodium bicarbonate (20 mL) and ethyl acetate (30 mL) were added. The organic layer was separated, washed with brine, dried (sodium sulfate) and concentrated in vacuo to give diethyl trans-1-benzyl-4-methoxypiperidin-3-ylphosphoramidate (1.70 g, 98%), which was used directly in the next step without purification.

Aufarbeitung

  1. temperatureThe resulting solution was warmed to room temperature
  2. stirringstirred at room temperature for 1 hour
  3. customThe solvent was removed in vacuo and saturated sodium bicarbonate (20 mL) and ethyl acetate (30 mL)
  4. additionwere added
  5. customThe organic layer was separated
  6. washwashed with brine
  7. dry with materialdried (sodium sulfate)
  8. concentrationconcentrated in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-51808887c0534ef6b623dcf1f4f896da
Quelldatensatz
uspto-grants-2015_03
Patentnummer
US08981085B2

Notizen zur Reaktion

Wird geladen…